PAHC
PAHC
NASDAQ · Pharmaceuticals

Phibro Animal Health Corp-A

$33.50
-1.90 (-5.37%)
As of Nov 7, 1:40 AM ET ·
Analyst Consensus
Strong Sell
9
Analysts
Moderate
Coverage
Buy 1 11%
Hold 4 44%
Sell 4 44%
Price Target
Analyst Price Target +221.5% upside
Low Target $71.95
Average Target $107.71
High Target $157.72
Current Price $33.50
Current
$33.50
Target
$107.71
$71.95 $107.71 avg $157.72
Scenario Analysis
Bear Case
$71.95
114.8%
Low target
Base Case
$107.71
+221.5%
Avg target
Bull Case
$157.72
+370.8%
High target
Risk/Reward
3.2x
Highly favorable
Price in Context
52-Week High
$60.08
-44.2% from high
52-Week Low
$28.25
+18.6% from low
50-Day SMA
$37.08
-9.7% vs SMA
200-Day SMA
$41.15
-18.6% vs SMA
RSI (14)
27.9
Oversold
Target vs 52W High
$107.71
+79.3% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $0.81
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%